Dernières nouvelles pour PROCEPT BioRobotics (NASDAQ:PRCT) Stock

PROCEPT BioRobotics

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

PROCEPT BioRobotics Corporation - Common Stock

PROCEPT BioRobotics Corp

JP Morgan analyst Kenneth Worthington maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Overweight and raises the price target from $92 to $95.

News

Price Target

Analyst Ratings

SCHW

JP Morgan Maintains Overweight on Charles Schwab, Raises Price Target to $95

Currency markets are becoming more volatile, which has been good news for traders who participate in their multi-trillion daily volume. CVIX, the index of market-implied currency volatility, surged above 10 in April as most currencies gained ground against the US dollar.
As usual, doomsday headlines indicate that taking a contrarian stance and scalping the dollar on the upside, at least for the short term, might be a wise choice.
Last week&#8217;s big central bank news went as expected, as the Bank of Canada held the rate steady while the European Central Bank cut yet another 25 bps. CPI news delivered another inflationary cooldown across the board, which will only be more stimulative for further rate cuts—but not yet for the dollar, due to <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44848474/fed-chair-powell-says-tariffs-lead-to-temporary-rise-in-inflation">hawkish commentary</a> from the FED&#8217;s Chairman Jerome Powell, which further reinstates the dollar&#8217;s short-term strength hypothesis.
The week ahead will bring <a href="https://singaporeforexclub.com/how-to-read-the-forex-economic-calendar">PMI news</a> from multiple markets, Bank of England Governor Bailey will speak on Wednesday, and the Swiss National Bank Chairman Schlegel&#8217;s speech will round up the fundamental news by Friday. The weekly focus will be on finding potential NZD weakness, EUR strength, or GBP strength.
Key News:
<ul>
<li>Tuesday: EUR – ECB President Lagarde Speech</li>
<li>Wednesday: EUR – French, German PMI, GBP – PMI, USD – PMI, GBP – Governor Bailey Speech</li>
<li>Thursday: USD – Unemployment Claims</li>
<li>Friday: GBP-Retail Sales, CAD–Retail Sales, CHF–Chairman Schlegel Speech</li>
</ul>
Pairs In Focus
1.EUR NZD
EUR/NZD has potentially completed its pullback, finding some footing toward the end of last week and reaching key levels from earlier this month. As long as price doesn&#8217;t close below 1.90880 on the daily chart, doesn&#8217;t establish a lower low, and keeps grinding higher—comfortably closing above the 1.92600 level, which is a key resistance on the hourly chart—the potential for an intra-week continuation is around 1.96250. Retail sentiment is 77% short, which reinforces the long thesis.
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="449" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102703/EURNZD_2025-04-20_22-26-50-1024x449.png" alt="" class="wp-image-11080" style="width:920px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102703/EURNZD_2025-04-20_22-26-50-1024x449.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102703/EURNZD_2025-04-20_22-26-50-300x132.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102703/EURNZD_2025-04-20_22-26-50-768x337.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102703/EURNZD_2025-04-20_22-26-50.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
EUR/NZD Daily Chart, Source: TradingView
2. GBP JPY
GBP JPY has printed an inside weekly bar. The price tried to take out last week&#8217;s low before failing and turning around. The anticipation for the next week is for a rally that will take out last week&#8217;s high, with the potential to reach as high as 191.900.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="454" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102809/GBPJPY_2025-04-20_22-25-38-1024x454.png" alt="" class="wp-image-11081" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102809/GBPJPY_2025-04-20_22-25-38-1024x454.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102809/GBPJPY_2025-04-20_22-25-38-300x133.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102809/GBPJPY_2025-04-20_22-25-38-768x340.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21102809/GBPJPY_2025-04-20_22-25-38.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
GBP/JPY Daily Chart, Source: TradingView
Ideally, an early week&#8217;s daily close above 190.130 would be a good opportunity to look for a follow-up pullback to set up the longs.
Notes:
<ul>
<li>AUD/CAD: Pulled back into support at 0.88500. As long as the price stays under 0.88750, it is a good candidate for a short.</li>
<li>AUD/NZD: Found some support around 1.07 but remains bearish.</li>
<li>AUD/SGD: Similar price action to AUD/CAD – the pullback seems temporarily finished, and <a href="https://singaporeforexclub.com/forex-price-action">price action</a> has</li>
<li>AUD/JPY:&nbsp; Failed to pull back to previous support—currently in a ranging phase.</li>
<li>AUD/CHF: Rejected the pullback; it might remain in a range for a while.</li>
<li>CAD/JPY: Remains in a consolidation, but the overall trend is to the downside.</li>
<li>CHF JPY: Pulled back after a huge breakout. As long as it stays above 173, the trend is to the upside.</li>
<li>EUR/AUD: The price has been compressing, and it will likely break out sometime soon. The bias is toward the upside.</li>
<li>EUR JPY: It didn't move as high as anticipated last week. Established support around 161.130 remains in play.</li>
<li>GBP/AUD: Found support around 2.07150. It looks ready for a sustained move to the upside.</li>
<li>GBP NZD: Pulled back to 2.25500 as anticipated and made a new lower low on the daily. The key level to watch above is 2.25120.</li>
<li>NZD/JPY: Staged a minor rally early in the week before crashing. Further downside movement is possible toward 82.900</li>
</ul>
Disclaimer: Any opinions expressed in this article are not to be considered investment advice and are solely those of the authors. <a href="https://singaporeforexclub.com">Singapore Forex Club</a> is not responsible for any financial decisions based on this article&#8217;s contents. Readers may use this data for information and educational purposes only.

Currency ETFs

Forex

Opinion

Trading Ideas

Currency Volatility Spikes As Central Banks Ponder Further Rate Cuts

Stephens &amp; Co. analyst Terry McEvoy reiterates Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) with a Equal-Weight and maintains $16.5 price target.

Reiteration

HBAN

Stephens & Co. Reiterates Equal-Weight on Huntington Bancshares, Maintains $16.5 Price Target

JP Morgan analyst Jessica Fye maintains BeiGene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONC#NASDAQ">ONC</a>) with a Overweight and raises the price target from $311 to $317.

JP Morgan Maintains Overweight on BeiGene, Raises Price Target to $317

<figure class="wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex"> 
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="1024" height="1024" data-id="11138" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21125941/image-11.png" alt="" class="wp-image-11138" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21125941/image-11.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21125941/image-11-300x300.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21125941/image-11-150x150.png 150w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21125941/image-11-768x768.png 768w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure> 
</figure>
<h2 class="wp-block-heading">A Power-Hungry AI Boom</h2>
The surge in artificial intelligence (AI) is transforming global energy markets, driven by the relentless electricity demands of data centers powering AI operations. These facilities require high-voltage, ultra-reliable power to ensure uninterrupted performance, as even a fleeting outage can derail complex computations, forcing operators to restart tasks from scratch. For investors, this trend signals a pivotal shift in energy commodities-natural gas, nuclear, and renewables-as companies race to meet escalating needs while navigating price volatility and infrastructure challenges.
<h2 class="wp-block-heading">Skyrocketing Energy Needs</h2>
Training advanced AI models, such as large language models, consumes vast amounts of electricity, far surpassing traditional data center requirements. For example, training GPT-3 required approximately 1,300 megawatt-hours, equivalent to the yearly energy use of 130 U.S. households, according to industry estimates. The more sophisticated GPT-4 likely demanded up to 50 times more, analysts suggest. Unlike conventional software, generative AI systems run continuously, amplifying their energy footprint. In 2024, global data center electricity consumption reached 460 terawatt-hours, per the International Energy Agency (<a href="https://www.iea.org/">IEA</a>), with AI-driven workloads contributing significantly. This spike pressures energy grids, pushing up electricity prices in key regions-U.S. industrial electricity rates rose 4.7% year-over-year in Q1 2025, per the U.S. Energy Information Administration (EIA)-and creating opportunities for energy-focused investments.
<h2 class="wp-block-heading">Infrastructure Under Strain</h2>
The Sixth Industrial Revolution, fueled by AI and sustainable technologies, is redefining energy infrastructure. Data centers accounted for 2.5% of global electricity use in 2024, per IEA projections, and this share is climbing as AI workloads grow exponentially. To cope, companies are investing heavily in localized power solutions. Microgrids, integrating solar and wind installations that supplied 17% of U.S. renewable energy in 2024, per the EIA, are emerging near data centers to stabilize supply. Battery storage systems, with global capacity hitting 120 gigawatt-hours in 2024, per <a href="https://about.bnef.com/new-energy-outlook/">BloombergNEF</a>, and smart grids are critical for managing fluctuating demands. These trends boost demand for commodities like lithium and nickel, essential for batteries, with lithium prices up 15% since January 2025, per S&amp;P Global Commodity Insights. Investors in these markets stand to benefit as infrastructure adapts.
<h2 class="wp-block-heading">A Pivot to Renewables and Innovation</h2>
Tech giants operating AI data centers, such as Microsoft and Google, which together consumed 25 terawatt-hours in 2024, per company reports, are targeting 100% renewable energy to curb emissions. This commitment drives billions into solar, wind, and small modular nuclear reactors (SMRs), with global clean energy investment reaching $1.8 trillion in 2024, per IEA data. On-site power generation-think hydrogen fuel cells and natural gas backup generators-is also gaining traction. Natural gas futures on the NYMEX rose 8% year-to-date in 2025, reflecting data center demand. Meanwhile, AI itself optimizes energy use. Machine learning predicts consumption patterns, enhancing grid efficiency and cutting costs, which could stabilize energy markets long-term but requires upfront capital-good news for investors in utilities and tech.
<h2 class="wp-block-heading">Hydrogen's Potential and Hurdles</h2>
Hydrogen emerges as a promising energy source for data centers, offering clean power with water as its primary byproduct. Its high energy density suits weight-sensitive applications, and hydrogen fuel cell installations grew 30% globally from 2023 to 2024, per the Hydrogen Council. Yet, challenges persist. Green hydrogen, made via renewable-powered electrolysis, costs $4-6 per kilogram in 2025, per BloombergNEF, far pricier than gray hydrogen at $1-2 per kilogram, which emits CO2. Blue hydrogen, with carbon capture, averages $2.5-3.5 per kilogram but faces scalability issues. These costs limit adoption, impacting hydrogen-related stocks like Plug Power (PLUG), down 12% year-to-date in 2025, per Yahoo Finance. Investors should watch for cost declines in green hydrogen to signal bullish trends.
<h2 class="wp-block-heading">What's Driving the Energy Shift?</h2>
AI's role in energy optimization is growing. Algorithms now forecast demand, improving grid stability and renewable integration. Battery technology advancements, with energy density up 10% from 2023 to 2024, per Wood Mackenzie, and cheaper solar panels, down 20% in cost since 2023, per Solar Energy Industries Association, accelerate the shift. Green hydrogen production costs are projected to fall 30% by 2030, per IEA forecasts, potentially unlocking its data center potential. For U.S. investors, this points to opportunities in natural gas (ETF: UNG), up 10% in 2025, and renewable energy funds (ETF: ICLN), gaining 15% year-to-date, per Morningstar, as infrastructure evolves.
<h2 class="wp-block-heading">A Market in Transformation</h2>
AI data centers are rewriting energy market rules, demanding reliable, sustainable power and driving up commodity prices like natural gas and lithium. While hydrogen holds promise, its high costs in 2025 temper enthusiasm. Investors can capitalize on this shift by eyeing energy ETFs and stocks tied to renewables and gas, but patience is key as infrastructure catches up. The Sixth Industrial Revolution is here, and energy markets are its backbone.

Commodities

AI Data Centers: Reshaping Energy Markets In The Sixth Industrial Revolution

Shares of Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) are trading lower by 3.7% to $483.12 during Monday&#8217;s session and are lower by 13% over the trailing week. The stock has been volatile following remarks last week from Federal Reserve Chair Jerome Powell that highlighted risks of persistent inflation and slower economic growth stemming from newly imposed <a href="https://www.benzinga.com/news/global/25/04/44899617/90-chance-of-recession-due-to-trumps-tariffs-sharp-slowdown-is-coming-economist-says">trade tariffs</a>.
Additionally, the U.S. government has kicked off a <a href="https://www.benzinga.com/news/25/04/44888906/meta-faces-an-antitrust-lawsuit-ftc-says-company-holds-a-social-network-monopoly">major antitrust trial against the company</a>, accusing it of maintaining a monopoly in social networking through years of anticompetitive practices. The Federal Trade Commission aims to force Meta to divest Instagram and WhatsApp. 
CEO Mark Zuckerberg testified on day one, defending Meta&#8217;s acquisition strategy. The case carries wide implications for other tech giants like Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>). Meta argues that its size is essential to competing globally, especially against platforms like TikTok.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44902410/unitedhealth-group-stock-is-getting-crushed-whats-fueling-the-selloff">UnitedHealth Group Stock Is Getting Crushed: What&#8217;s Fueling The Selloff?</a>
What Else: Meta, which generates the bulk of its revenue from digital advertising, is particularly sensitive to macroeconomic slowdowns. <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44848474/fed-chair-powell-says-tariffs-lead-to-temporary-rise-in-inflation">Powell's comments</a> that first-quarter growth has softened and inflation remains above target spooked investors already wary of margin pressures and ad budget pullbacks.
Tariffs raise input costs across industries, including for hardware Meta relies on for its VR and AR platforms. If inflation accelerates due to supply chain distortions, <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/04/44643664/top-3-consumer-stocks-that-are-set-to-fly-this-quarter">consumer</a> spending may also decline, pressuring advertisers to scale back spending on platforms like Facebook, Instagram and Threads.
Moreover, Powell&#8217;s signal that the Fed may delay rate cuts adds another headwind. Higher interest rates weigh on tech stock valuations and increase the cost of capital for Meta's long-horizon projects in the metaverse and AI infrastructure.
Growing business sentiment uncertainty could also further delay corporate digital ad spend recovery.
Read Also: <a href="https://www.benzinga.com/25/04/44896337/teslas-q1-test-drive-will-earnings-steer-tesla-stock-out-of-the-ditch">Tesla Q1 Test Drive: Will Earnings Steer The Stock Out Of The Ditch?</a>
<h2 class="wp-block-heading">How To Buy META Stock</h2>
By now you're likely curious about how to participate in the market for Meta Platforms &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Meta Platforms, which is trading at $482.53 as of publishing time, $100 would buy you about 0.21 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, META has a 52-week high of $740.91 and a 52-week low of $414.50.

AMZN

GOOG

GOOGL

Meta Platforms Stock Falls Amid Antitrust Trial, Tariff And Inflation Concerns: What's Going On?

Truist Securities analyst Tobey Sommer maintains ManpowerGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) with a Hold and lowers the price target from $55 to $48.

Truist Securities Maintains Hold on ManpowerGroup, Lowers Price Target to $48

XPANCEO founders on building the first interface designed for the body, not the screen — and why human–tech integration is the next leap forward.
When it comes to the future of interfaces, we're used to bold claims: AR glasses will replace phones. Brain-computer interfaces will merge us with machines. But beneath the noise, the real breakthroughs start in a lab, where biology meets engineering, and technology is made compact enough to work inside the human body itself. That's where <a href="https://xpanceo.com/">XPANCEO</a> is operating — developing something deceptively small: a smart contact lens.
We could just stop at the technical side of things — describing it as a compact, next-gen device with integrated microdisplays, biosensors, and wireless power delivery. But that wouldn't capture what makes it significant — because what XPANCEO is building is a new kind of interface, one designed not for screens, but for the human body itself.&nbsp;
I spoke with founders <a href="https://www.linkedin.com/in/romanaxelrod/">Roman Axelrod</a> and <a href="https://www.linkedin.com/in/valentyn-volkov/">Dr. Valentyn Volkov</a> to better understand the science, the challenges, and what it means to build an interface that's so intimate it's worn on the surface of the eye.
<h2 class="wp-block-heading">Why Downscaling Doesn't Work — And What Does</h2>
Rather than downsizing existing smartphone components, XPANCEO had to rethink materials entirely, focusing on implementing next-generation technologies specifically designed for ultra-small-scale applications.&nbsp;
"The conventional approach — shrinking phone components into something eye-sized — doesn't work," Dr. Valentyn Volkov explained. "It's not just a size problem; it's about weight, power efficiency, and heat dissipation. So we had to rethink everything."
XPANCEO approached the contact lens from the ground up — not as a wearable gadget, but as a biologically integrated system. The team needed flexibility, conductivity, and high performance in an exceptionally small format. So they turned to novel ultra-thin 2D materials — just atoms thick&nbsp; — small and light enough to fit into a contact lens, yet capable of maintaining high performance.&nbsp;
That progress, however, relied not just on materials — but primarily on expertise. Co-founder Dr. Valentyn Volkov, with a background in nanophotonics, nano-optics, and applied research across leading international institutions, helped bring together materials science, AI, and next-gen optics to build systems that work reliably at a microscopic scale.
"His know-how was vital to helping us design and fine-tune systems that work reliably at such a small scale," Axelrod said, noting that this level of precision is absolutely essential to building technology for the surface of the eye.
<h2 class="wp-block-heading">A Smarter Way to Know When to See a Doctor</h2>
By detecting biomarkers like glucose and hormone levels in the user&#8217;s tear fluid, the contact lens can be used for non-stop, non-invasive health monitoring. Spotting problems early becomes a reality thanks to these biosensing capabilities, which also help create personalized prevention plans.
Naturally, I wanted to know how this stacks up against the gold standard — so I asked whether tear-based readings could ever rival the accuracy of blood diagnostics.
Dr. Volkov acknowledged this challenge but was careful to draw the line between potential and clinical equivalence:
"It's true — biomarker levels in tear fluid are way lower than in blood, sometimes by orders of magnitude. But we've developed highly sensitive detection systems that can pick up and amplify those weak signals — using advanced nanomaterials, smart signal processing, and built-in electronics right inside the contact lens."
"That said, we want to be clear about where things stand. We're already seeing good results detecting some clinically relevant biomarkers, but we're not quite at blood-test-level accuracy at the moment. So for now, we're not ready to say it's on par with gold-standard blood diagnostics just yet."
He added that the goal is not to displace diagnostics at all:
&nbsp;"We're building a complementary layer — a longitudinal view that may one day signal when a deeper test is warranted."&nbsp;
Unlike standard lab tests, which only capture isolated snapshots of a person's health, the contacts are designed to provide a real-time stream of physiological data. This ongoing perspective can help reveal early warning signs or subtle deviations in biomarker levels — the kind that might go unnoticed in traditional diagnostics — and prompt the user to consult a physician before symptoms even appear.&nbsp;
The team is also exploring integration with drug delivery systems through the contact lens, which is especially relevant for chronic conditions like glaucoma or dry eye syndrome. According to Dr. Volkov, this could help improve medication adherence and fine-tuning of dosages by linking drug release to real-time biomarker levels.
"We're not trying to replace clinical diagnostics — we're creating a system that can detect when something's off," he explained. "Smart contact lenses might not be ready for clinical use just yet, but they're already shaping up to be a powerful preventive health companion."
<h2 class="wp-block-heading">No Screens, No Swipes — So How Do You Interact with It?</h2>
Interaction was never going to follow the smartphone model. You can't pinch or tap your cornea. Instead, XPANCEO is exploring several input methods — some familiar, others deeply biological.
You might not think about it often, but your tongue is one of the most electrically active and sensitive muscles in the body. It's packed with nerves, and every movement it makes generates tiny bioelectrical signals — a fact that forms the basis of what scientists call glossokinetic control.&nbsp;
Recognizing this, Dr. Volkov and his team at XPANCEO are exploring how these signals can be used to interact with digital content:
"It's a discreet and precise method, well-suited to everyday use, without the need for touchscreens or gestures."
The eye-tracking system is equally hands-free, allowing users to select and navigate digital elements just by looking.
"The contact lens has a patent-pending eye-tracking system built in," he said. "It lets people interact with content just by shifting their gaze — it's fast, natural, and invisible to others."
Facial micro-expressions and voice input offer additional layers of control, making the system adaptable to different settings and needs. While voice isn't ideal in crowded or public environments, it can still serve as a reliable fallback — especially when paired with AI that can interpret user intent.
"We're working toward a multimodal interaction system that adapts to the user — not the other way around," Dr. Volkov added. "It's about making the tech adjust to your context, not forcing you to adapt to the tech."
<h2 class="wp-block-heading">The Smart Contact Lens Shift: Screens, Safety, and Social Norms</h2>
Smart contacts, if they scale, won't replace screens — they'll just rearrange them.
"Screens will still exist," Axelrod said. "But they'll become less central. Just like smartphones didn't eliminate PCs, smart contacts won't eliminate other interfaces — they'll just push them to evolve into forms that feel more natural."
What makes this shift so significant isn't just the technology itself — it's the intimacy of the interface. This isn't a wearable. It's something worn directly on the eye. It becomes, in a sense, part of the body. And that raises questions far beyond user experience — from surveillance and privacy to social norms and the psychological effects of persistent AR.
"People didn't reject the technology — they rejected how alien it made the wearer look," Axelrod said, referring to early reactions to headsets like Vision Pro. "That's not a problem for something as discreet as a contact lens."
But discreet doesn't mean invisible in terms of impact. As with any tech that disappears into the body, new boundaries will need to emerge — and the XPANCEO team is building with that in mind.
Because the contact lens is worn on the eye, XPANCEO is treating it not as a consumer gadget, but as a medical device. Roman Axelrod said the company is preparing for pre-clinical trials and expects full-lens trials to begin by the end of 2026:
"There's no shortcut around biocompatibility testing and clinical validation," he said. "These processes are detailed and time-consuming, yet absolutely essential."
The regulatory landscape for this kind of technology doesn't fully exist yet, which puts XPANCEO in the position of helping define what compliance looks like for ocular XR systems.
And safety isn't only about biology. With sensors potentially collecting biometric or environmental data, Axelrod noted that safeguards are being built directly into the system — including AI-powered restrictions that limit use in sensitive or high-risk environments.
"We've heard it all — from students dreaming of passing exams without studying to people picturing themselves watching YouTube while driving," he said. "As funny as it sounds, it's exactly why smart systems need smart limits."
"Of course, no technology can eliminate misuse entirely — people still use phones where they shouldn't," he added. "But we're building safeguards into the contact lens itself to encourage responsible use and ensure it complies with local laws and regulations."
<h2 class="wp-block-heading">Toward the Next Evolution of Human</h2>
To hear Axelrod describe it, XPANCEO's project isn't just about engineering a contact lens. It's about building a proof of concept for a broader shift — from external tools to internal augmentation.
"I believe we're heading toward a transhumanist future — not in a speculative sense, but in a technical one," he said. "The capabilities we'll need to survive in space, treat neurodegenerative diseases, or even expand our sensory range — those won't come from devices we hold. They'll come from ones we integrate."
That may sound like ideology. But when you're embedding systems directly onto the eye — and they work — it becomes harder to dismiss the possibility.&nbsp;
And Axelrod doesn't see XPANCEO as the only player in this shift. As more companies blur the line between biology and technology, he sees a future where human potential itself begins to evolve:
"Over the next decade, I think we'll start to see what it really means when biology and tech become indistinguishable. This isn't just about convenience. It's about expanding what humans are capable of — to become more adaptive, more resilient, and even interplanetary."
Whether or not that future unfolds exactly as imagined, the trajectory feels unmistakable. The contact lens, in this sense, is a first step — a signal that the most powerful interfaces may not be the ones that dazzle, but the ones that disappear into the body, bringing us closer to a world where human limitations are no longer the end of the story.

Health Care

Tech

Interview

The Next Human Evolution Starts At The Surface Of The Eye: A Conversation With XPANCEO's Founders On Human-Integrated Interfaces

Old National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.
Analysts estimate that Old National will report an earnings per share (EPS) of $0.43. 
Anticipation surrounds Old National's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.03, leading to a 0.93% drop in the share price the following trading session.
Here's a look at Old National's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.46</td>
<td>0.46</td>
<td>0.44</td>
<td>0.43</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.49</td>
<td>0.46</td>
<td>0.46</td>
<td>0.45</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>0.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745251334_0.png" alt="eps graph" />
<h3>Tracking Old National's Stock Performance</h3>
Shares of Old National were trading at $19.59 as of April 18. Over the last 52-week period, shares are up 16.27%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/ONB/earnings">To track all earnings releases for Old National visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Insights into Old National's Upcoming Earnings

West Fraser Timber (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFG#NYSE">WFG</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.
Analysts are estimating that West Fraser Timber will report an earnings per share (EPS) of $0.56.
The announcement from West Fraser Timber is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.04, which was followed by a 3.83% drop in the share price the next day.
Here's a look at West Fraser Timber's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.06</td>
<td>-0.50</td>
<td>1.32</td>
<td>0.30</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.10</td>
<td>-1.03</td>
<td>1.20</td>
<td>0.42</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>1.0%</td>
<td>7.000000000000001%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745251325_0.png" alt="eps graph" />
<h3>Performance of West Fraser Timber Shares</h3>
Shares of West Fraser Timber were trading at $73.29 as of April 18. Over the last 52-week period, shares are down 8.02%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/WFG/earnings">To track all earnings releases for West Fraser Timber visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What to Expect from West Fraser Timber's Earnings

Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.
Analysts estimate that Range Resources will report an earnings per share (EPS) of $0.89. 
Anticipation surrounds Range Resources's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.08 in the last quarter, leading to a 2.8% increase in the share price on the following day.
Here's a look at Range Resources's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.60</td>
<td>0.38</td>
<td>0.42</td>
<td>0.57</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.68</td>
<td>0.48</td>
<td>0.46</td>
<td>0.69</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>4.0%</td>
<td>-4.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745251314_0.png" alt="eps graph" />
<h3>Tracking Range Resources's Stock Performance</h3>
Shares of Range Resources were trading at $34.18 as of April 18. Over the last 52-week period, shares are down 9.49%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Observations about Range Resources</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Range Resources.
Range Resources has received a total of 15 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $41.27, the consensus suggests a potential 20.74% upside.
<h3>Peer Ratings Comparison</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Permian Resources, Ovintiv and APA, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Permian Resources, with an average 1-year price target of $18.5, suggesting a potential 45.87% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Ovintiv, with an average 1-year price target of $51.5, suggesting a potential 50.67% upside.</li>
<li>Analysts currently favor an Neutral trajectory for APA, with an average 1-year price target of $25.55, suggesting a potential 25.25% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
In the peer analysis summary, key metrics for Permian Resources, Ovintiv and APA are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Range Resources</td>
<td>Neutral</td>
<td>4.50%</td>
<td>$207.72M</td>
<td>2.42%</td>
</tr>
<tr>
<td>Permian Resources</td>
<td>Outperform</td>
<td>15.44%</td>
<td>$575.46M</td>
<td>2.45%</td>
</tr>
<tr>
<td>Ovintiv</td>
<td>Outperform</td>
<td>-30.89%</td>
<td>$1.19B</td>
<td>-0.57%</td>
</tr>
<tr>
<td>APA</td>
<td>Neutral</td>
<td>25.15%</td>
<td>$1.10B</td>
<td>6.81%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Range Resources is positioned in the middle among its peers for revenue growth, with a growth rate of 4.50%. It ranks at the bottom for gross profit at $207.72M. In terms of return on equity, Range Resources is also at the bottom with a rate of 2.42%.
<h3>Discovering Range Resources: A Closer Look</h3>
Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.
<h3>Range Resources: Delving into Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining Range Resources's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.5% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Range Resources's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 14.16%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Range Resources's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.42%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 1.29%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Range Resources's debt-to-equity ratio is below the industry average at 0.46, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/RRC/earnings">To track all earnings releases for Range Resources visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Range Resources's Earnings: A Preview

Kevin O&#8217;Leary is standing firmly behind Donald Trump&#8217;s trade policies, especially when it comes to China. During a recent appearance on <a href="https://www.youtube.com/watch?v=ztWvIPUxT0s">MSNBC</a>, the &#8220;Shark Tank&#8221; investor and chair of O&#8217;Leary Ventures dismissed the idea that tariffs are harming American companies. Instead, he said <a href="https://www.benzinga.com/markets/equities/25/04/44711364/kevin-oleary-calls-for-hefty-400-us-tariffs-on-china-they-dont-play-by-the-rules">they&#8217;re overdue</a>.
<h2 class="wp-block-heading">Tariffs Are Just One Part of the Strategy</h2>
O&#8217;Leary argued that Trump's approach to negotiating tariffs with more than 60 countries is something no other administration has tried. &#8220;Usually, you do a NAFTA-kind of deal,&#8221; he said. &#8220;This is just different.&#8221;
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>
He believes most of those situations will work themselves out, even naming countries like Vietnam and Germany as examples of those already engaging with the U.S. on trade talks. For him, those are manageable.
<h2 class="wp-block-heading">The Bigger Problem Is China</h2>
The real threat, O&#8217;Leary said, is China. &#8220;China is cheating, stealing, ripping off IP, wiping out American companies—many of them mine,&#8221; he said. He claimed that since joining the World Trade Organization in 2000, China has ignored intellectual property laws, costing the U.S. dearly.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I wanna solve this because I&#39;m a guy that actually does business there and I&#39;m telling you, they wipe out thousands, if not millions, of American companies that get to five million in sales. I&#39;m just one voice, but I think that narrative&#39;s starting to pick up a little momentum… <a href="https://t.co/IUGFh9vuZo">pic.twitter.com/IUGFh9vuZo</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1912274762874704090?ref_src=twsrc%5Etfw">April 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;They don&#8217;t even care about IP laws. It's beyond ridiculous,&#8221; he said. O&#8217;Leary estimated that millions of U.S. businesses have been harmed, especially small ones. &#8220;I'm just speaking on behalf of every small entrepreneur in America, and I think I have my army behind me,&#8221; he said.
Trending: With high-demand properties in the Midwest, Bam Capital has delivered 2.46x equity multiples in just over 3 years. No losses. No missed payments. <a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">Learn more about becoming an investor today</a>.&nbsp;
Adding to the broader conversation around intellectual property, Elon Musk, CEO of Tesla, and Jack Dorsey, co-founder of Twitter and Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), have stirred debate recently by <a href="https://www.benzinga.com/markets/25/04/44783776/elon-musk-jack-dorsey-call-for-abolition-of-all-intellectual-property-laws-arguing-there-are-much-greater-models-to-pay-creators">suggesting the complete eradication of IP laws</a>. The idea has sparked controversy across the tech industry, with some seeing it as innovative and others viewing it as dangerous.
<h2 class="wp-block-heading">A Game of Leverage</h2>
While critics like economist Paul Krugman and investor <a href="https://www.benzinga.com/personal-finance/25/04/44778587/we-are-heading-for-a-self-induced-economic-nuclear-winter-billionaire-investor-bill-ackman-has-turned-on-trump-over-tariffs">Bill Ackman have called the trade war</a> risky or a failure, O&#8217;Leary disagreed. He believes the only way to deal with China is through leverage. &#8220;This is a game of chicken right now,&#8221; he said, adding that higher tariffs may be necessary to bring China to the negotiating table.
O&#8217;Leary said he doesn&#8217;t support politicians, just policy. He emphasized that while many people are focused on hating Trump, they&#8217;re missing the policy argument. &#8220;There are millions of American companies wiped out by what China does,&#8221; he said. &#8220;I don't know why you're okay with it. You shouldn't be.&#8221;
He continued, &#8220;62% of jobs in America are created by companies with 5 to 500 employees. I am their advocate and we&#8217;re pissed.&#8221;
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">Hope for Progress</h2>
Despite the friction, O&#8217;Leary said he still wants to do business with China and sees opportunity there. But he said that the current situation can't continue. &#8220;We want to form some kind of a union that's not so antagonistic. But you can't cheat, you can&#8217;t steal,&#8221; he said.&nbsp;
He&#8217;s optimistic that the trade policy will start to show results soon. &#8220;Give it a few weeks,&#8221; he said. &#8220;I think we're going to get something worked out here. <a href="https://www.benzinga.com/news/global/25/04/44777274/kevin-oleary-says-xi-jinping-is-playing-with-fire-if-this-gamble-doesnt-pay-off">Xi is also in a bad place</a>.&#8221;
In the meantime, he says he&#8217;s speaking for the small businesses that can&#8217;t afford to keep losing to a system that, in his view, has been rigged for too long.
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Image: Shutterstock

Kevin O'Leary Says China's Actions Have 'Wiped Out' Millions Of American Companies—'I Don't Know Why Anyone Is Okay With It'

Agree Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Agree Realty to report an earnings per share (EPS) of $1.05.
Investors in Agree Realty are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.01, leading to a 1.65% drop in the share price the following trading session.
Here's a look at Agree Realty's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.03</td>
<td>1.03</td>
<td>1.03</td>
<td>1.01</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.04</td>
<td>1.03</td>
<td>1.04</td>
<td>1.03</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>2.0%</td>
<td>2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745251305_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Agree Realty were trading at $79.05 as of April 18. Over the last 52-week period, shares are up 36.71%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Insights Shared by Analysts on Agree Realty</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Agree Realty.
Analysts have provided Agree Realty with 6 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $78.0, suggesting a potential 1.33% downside.
<h3>Comparing Ratings with Competitors</h3>
The below comparison of the analyst ratings and average 1-year price targets of Federal Realty Investment, NNN REIT and Brixmor Property Group, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Federal Realty Investment, with an average 1-year price target of $113.22, suggesting a potential 43.23% upside.</li>
<li>Analysts currently favor an Neutral trajectory for NNN REIT, with an average 1-year price target of $44.17, suggesting a potential 44.12% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Brixmor Property Group, with an average 1-year price target of $29.61, suggesting a potential 62.54% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
The peer analysis summary outlines pivotal metrics for Federal Realty Investment, NNN REIT and Brixmor Property Group, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Agree Realty</td>
<td>Outperform</td>
<td>11.49%</td>
<td>$140.37M</td>
<td>0.83%</td>
</tr>
<tr>
<td>Federal Realty Investment</td>
<td>Outperform</td>
<td>6.73%</td>
<td>$209.50M</td>
<td>2.09%</td>
</tr>
<tr>
<td>NNN REIT</td>
<td>Neutral</td>
<td>1.04%</td>
<td>$207.34M</td>
<td>2.24%</td>
</tr>
<tr>
<td>Brixmor Property Group</td>
<td>Neutral</td>
<td>3.78%</td>
<td>$242.50M</td>
<td>2.84%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Agree Realty ranks highest in Revenue Growth among its peers. It has the lowest Gross Profit margin. The company's Return on Equity is the lowest among its peers. Overall, Agree Realty is positioned in the middle compared to its peers in terms of consensus rating.
<h3>Delving into Agree Realty's Background</h3>
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
<h3>Agree Realty's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Agree Realty's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 11.49%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Agree Realty's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 26.92% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Agree Realty's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.83%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Agree Realty's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.52%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Agree Realty's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.53.
<a href="https://www.benzinga.com/quote/ADC/earnings">To track all earnings releases for Agree Realty visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look at Agree Realty's Upcoming Earnings Report

Stephens &amp; Co. analyst Matt Olney reiterates Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) with a Overweight and maintains $33 price target.

HOMB

Stephens & Co. Reiterates Overweight on Home BancShares, Maintains $33 Price Target

Valmont Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.
Analysts estimate that Valmont Industries will report an earnings per share (EPS) of $4.36. 
Investors in Valmont Industries are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat EPS by $0.22, which was followed by a 2.58% drop in the share price the next day.
Here's a look at Valmont Industries's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>3.62</td>
<td>4</td>
<td>4.08</td>
<td>3.25</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>3.84</td>
<td>4.11</td>
<td>4.76</td>
<td>4.32</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.0%</td>
<td>10.0%</td>
<td>11.0%</td>
<td>18.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745251294_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Valmont Industries were trading at $277.83 as of April 18. Over the last 52-week period, shares are up 26.72%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on Valmont Industries</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Valmont Industries.
The consensus rating for Valmont Industries is Buy, based on 4 analyst ratings. With an average one-year price target of $383.75, there's a potential 38.12% upside.
<h3>Comparing Ratings with Competitors</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Fluor, Dycom Industries and Construction Partners, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Fluor, with an average 1-year price target of $48.62, suggesting a potential 82.5% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Dycom Industries, with an average 1-year price target of $199.83, suggesting a potential 28.07% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Construction Partners, with an average 1-year price target of $98.5, suggesting a potential 64.55% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
The peer analysis summary offers a detailed examination of key metrics for Fluor, Dycom Industries and Construction Partners, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Valmont Industries</td>
<td>Buy</td>
<td>2.14%</td>
<td>$313.02M</td>
<td>5.04%</td>
</tr>
<tr>
<td>Fluor</td>
<td>Buy</td>
<td>11.52%</td>
<td>$208M</td>
<td>60.10%</td>
</tr>
<tr>
<td>Dycom Industries</td>
<td>Outperform</td>
<td>13.87%</td>
<td>$196.58M</td>
<td>2.64%</td>
</tr>
<tr>
<td>Construction Partners</td>
<td>Neutral</td>
<td>41.63%</td>
<td>$76.57M</td>
<td>-0.44%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Valmont Industries ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth and below average for Consensus rating.
<h3>Discovering Valmont Industries: A Closer Look</h3>
Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting and transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.
<h3>Understanding the Numbers: Valmont Industries's Finances</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Valmont Industries displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 2.14%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Valmont Industries's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 7.49%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Valmont Industries's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 5.04%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Valmont Industries's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 2.27%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Valmont Industries's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.56.
<a href="https://www.benzinga.com/quote/VMI/earnings">To track all earnings releases for Valmont Industries visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Valmont Industries

JP Morgan analyst Domingos Falavina maintains Banco Macro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMA#NYSE">BMA</a>) with a Neutral and raises the price target from $78 to $89.

JP Morgan Maintains Neutral on Banco Macro, Raises Price Target to $89

Synchrony Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.
Analysts estimate that Synchrony Finl will report an earnings per share (EPS) of $1.67. 
The market awaits Synchrony Finl's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
Last quarter the company missed EPS by $0.01, which was followed by a 3.17% increase in the share price the next day.
Here's a look at Synchrony Finl's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.92</td>
<td>1.79</td>
<td>1.35</td>
<td>1.35</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.91</td>
<td>1.94</td>
<td>1.55</td>
<td>1.18</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>0.0%</td>
<td>-3.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745251281_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Synchrony Finl were trading at $47.87 as of April 18. Over the last 52-week period, shares are up 8.48%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Opinions on Synchrony Finl</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Synchrony Finl.
The consensus rating for Synchrony Finl is Neutral, based on 9 analyst ratings. With an average one-year price target of $67.11, there's a potential 40.19% upside.
<h3>Comparing Ratings with Competitors</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of FirstCash Hldgs and Enova International, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for FirstCash Hldgs, with an average 1-year price target of $137.0, suggesting a potential 186.19% upside.</li>
<li>Analysts currently favor an Buy trajectory for Enova International, with an average 1-year price target of $134.5, suggesting a potential 180.97% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary provides a snapshot of key metrics for FirstCash Hldgs and Enova International, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Credit Acceptance</td>
<td>Neutral</td>
<td>14.89%</td>
<td>$351.10M</td>
<td>8.95%</td>
</tr>
<tr>
<td>FirstCash Hldgs</td>
<td>Outperform</td>
<td>3.72%</td>
<td>$433.69M</td>
<td>4.12%</td>
</tr>
<tr>
<td>Enova International</td>
<td>Buy</td>
<td>25.01%</td>
<td>$336.05M</td>
<td>5.36%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Synchrony Financial ranks in the middle among its peers for Consensus rating. It is at the top for Revenue Growth, indicating strong performance in this area. In terms of Gross Profit, Synchrony Financial is at the top compared to its peers. However, for Return on Equity, it is at the bottom among the group.
<h3>About Synchrony Finl</h3>
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).
<h3>Unraveling the Financial Story of Synchrony Finl</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Synchrony Finl displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 3.88%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 19.81%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Synchrony Finl's ROE stands out, surpassing industry averages. With an impressive ROE of 5.0%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.63%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 1.01, Synchrony Finl adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/SYF/earnings">To track all earnings releases for Synchrony Finl visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Synchrony Finl's Earnings

Truist Securities analyst Jordan Levy maintains Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) with a Hold and lowers the price target from $22 to $19.

Truist Securities Maintains Hold on Bloom Energy, Lowers Price Target to $19

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Equifax to report an earnings per share (EPS) of $1.84.
The announcement from Equifax is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 0.32% increase in the share price the next day.
Here's a look at Equifax's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.10</td>
<td>1.83</td>
<td>1.73</td>
<td>1.44</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.12</td>
<td>1.85</td>
<td>1.82</td>
<td>1.50</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>-3.0%</td>
<td>2.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745251271_0.png" alt="eps graph" />
<h3>Tracking Equifax's Stock Performance</h3>
Shares of Equifax were trading at $221.25 as of April 18. Over the last 52-week period, shares are down 3.56%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Opinions on Equifax</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Equifax.
Equifax has received a total of 9 ratings from analysts, with the consensus rating as Outperform. With an average one-year price target of $296.44, the consensus suggests a potential 33.98% upside.
<h3>Comparing Ratings with Competitors</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Leidos Holdings, Jacobs Solutions and TransUnion, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Leidos Holdings, with an average 1-year price target of $172.83, suggesting a potential 21.88% downside.</li>
<li>Analysts currently favor an Buy trajectory for Jacobs Solutions, with an average 1-year price target of $146.0, suggesting a potential 34.01% downside.</li>
<li>Analysts currently favor an Neutral trajectory for TransUnion, with an average 1-year price target of $108.25, suggesting a potential 51.07% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary outlines pivotal metrics for Leidos Holdings, Jacobs Solutions and TransUnion, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Equifax</td>
<td>Outperform</td>
<td>7.00%</td>
<td>$804.40M</td>
<td>3.59%</td>
</tr>
<tr>
<td>Leidos Holdings</td>
<td>Outperform</td>
<td>9.67%</td>
<td>$693M</td>
<td>6.29%</td>
</tr>
<tr>
<td>Jacobs Solutions</td>
<td>Buy</td>
<td>4.37%</td>
<td>$721.27M</td>
<td>-0.31%</td>
</tr>
<tr>
<td>TransUnion</td>
<td>Neutral</td>
<td>8.65%</td>
<td>$625.20M</td>
<td>1.57%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Equifax ranks first in gross profit and return on equity among its peers. It ranks second in revenue growth and consensus rating.
<h3>About Equifax</h3>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Understanding the Numbers: Equifax's Finances</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Over the 3 months period, Equifax showcased positive performance, achieving a revenue growth rate of 7.0% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Equifax's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 12.26%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Equifax's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.59%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Equifax's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.44%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Equifax's debt-to-equity ratio is below the industry average. With a ratio of 1.04, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/EFX/earnings">To track all earnings releases for Equifax visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look Ahead: Equifax's Earnings Forecast

PulteGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.
Analysts estimate that PulteGroup will report an earnings per share (EPS) of $2.44. 
The market awaits PulteGroup's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company beat EPS by $0.23, leading to a 3.99% drop in the share price the following trading session.
Here's a look at PulteGroup's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>3.27</td>
<td>3.11</td>
<td>3.27</td>
<td>2.36</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>3.50</td>
<td>3.35</td>
<td>3.58</td>
<td>2.87</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-0.0%</td>
<td>-2.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745251263_0.png" alt="eps graph" />
<h3>Market Performance of PulteGroup's Stock</h3>
Shares of PulteGroup were trading at $94.95 as of April 18. Over the last 52-week period, shares are down 17.84%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/PHM/earnings">To track all earnings releases for PulteGroup visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: PulteGroup's Quarterly Earnings

Press Releases

Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

Short Sellers

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Comments

PROCEPT BioRobotics

Actualités

Dernières nouvelles pour PROCEPT BioRobotics (NASDAQ:PRCT) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL